Low-Dose vs High-Dose Paclitaxel-Coated Balloons for Femoropopliteal Lesions 2-Year Results From the COMPARE TrialJACC-CARDIOVASCULAR INTERVENTIONSIF11.42022-10-0113OAAI
Assessment of 5-Year Mortality Outcomes for Femoropoliteal Interventions Using Drug-Eluting Devices in the REAL-PTX StudyJACC-CARDIOVASCULAR INTERVENTIONSIF11.42021-05-010PREAI
Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac TrialRADIOLOGYIF15.22020-05-0129PREAI
Efficacy and safety o a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trialEUROINTERVENTIONIF9.52020-04-0117PRE
COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventionsEUROPEAN HEART JOURNALIF35.62020-01-2855OAAI
Statin therapy may be associated with lower mortality in patients with diastolic heart failure - A preliminary reportCIRCULATIONIF38.62005-07-19247OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向